Work

Ondansetron versus palonosetron as a marker of non-adherence to antiemetic prophylaxis guidelines in highly emetogenic chemotherapy.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.e23108

Authors: Eric Roeland, Kathryn Jean Ruddy, Thomas William LeBlanc, Rebecca Anne Clark-Snow, Rita S. Wickham, Gary Binder, Silvia Sebastiani, Ravi C. Potluri, Eros Papademetriou, Luke M. Schmerold, Rudolph M. Navari

Institutions: Massachusetts General Hospital, Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Duke Medical Center, Rush University, Helsinn Therapeutics (United States), Helsinn (Switzerland), University of Alabama at Birmingham

Language: English

Topic: Nausea and vomiting management

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947553006

Cites:

Cited by:

Related to: 10